Wilson Sonsini Goodrich & Rosati has advised Iambic. Iambic, a clinical-stage life science and technology company, has announced the completion of an oversubscribed financing round, raising...
Iambic Raises Over $100 Million in Oversubscribed Financing Round
Evernorth Announces Over $1 Billion Public Launch via Business Combination with Armada Acquisition Corp II
Davis Polk & Wardwell has advised Evernorth and Ripple. Skadden has advised Citigroup Global Markets Inc. Wilson Sonsini Goodrich & Rosati and Mourant have advised Armada...
Tenstorrent Acquires Blue Cheetah Analog Design
Wilson Sonsini Goodrich & Rosati has advised Tenstorrent on the transaction. Tenstorrent, a next-generation computing company focused on building computers for artificial intelligence, has announced the...
Soleno Therapeutics Announces $200 Million Public Offering
Wilson Sonsini Goodrich & Rosati and Cooley LLP have advised Soleno Therapeutics, Inc. on the deal. Mintz has advised the underwriters. Soleno Therapeutics, Inc. has announced...
Luminar Technologies’ $200 Million Convertible Preferred Stock Offering
Orrick, Herrington & Sutcliffe advised Luminar Technologies on the offering, and Wilson Sonsini Goodrich & Rosati advised D. Boral Capital as the exclusive placement agent on...
Weave Communications’ Acquisition of TrueLark
Wilson Sonsini Goodrich & Rosati advised Weave on the transaction. Weave, a Lehi (NYSE: WEAV), UT-based provider of a customer experience and payments software platform, announced...
Alleviant Medical’s $90 Million Equity Financing
Wilson Sonsini Goodrich & Rosati advised Alleviant Medical on the transaction. Alleviant Medical, Inc., a privately held medical device company, announced a $90 million financing to...
USANA Health Sciences’ Acquisition of Hiya Health
Wilson Sonsini Goodrich & Rosati advised USANA Health Sciences, while Bodman PLC acted as Hiya’s legal advisor. Fried Frank acted as counsel to BofA Securities as...
Lumos Pharma’s Tender Offer and Merger with Double Point Ventures
Wilson Sonsini Goodrich & Rosati and Cooley advised Lumos Pharma on the transaction, while Foley & Lardner advised Double Point Ventures. Lumos Pharma (NASDAQ:LUMO), a clinical...
Tenstorrent’s $693 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati advised Tenstorrent on the transaction. Tenstorrent, a next-generation computing company that builds computers for AI, announced the closing of over $693...
Microchip Technology’s $1 Billion Senior Notes Offering
Wilson Sonsini Goodrich & Rosati represented Microchip Technology Incorporated in the offering, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) (Nasdaq: MCHP) priced...
Tenstorrent’s $100 Million Financing Round
Wilson Sonsini Goodrich & Rosati represented Tenstorrent in the transaction. Tenstorrent announced that it closed a $100 million strategic financing up-round led by Hyundai Motor Group...